Dark Forest Capital Management’s Haemonetics HAE Stock Holding History

Dark Forest Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$347K	Sell	6,154 -9,085	-60%	-$592K	0.03%	643
2025 Q4	$1.22M	Sell	15,239 -18,664	-55%	-$1.25M	0.06%	586
2025 Q3	$1.65M	Buy	33,903 +18,207	+116%	+$1.13M	0.06%	544
2025 Q2	$1.17M	Buy	+15,696	New	+$1.04M	0.05%	687
2025 Q1	–	Sell	-4,720	Closed	-$369K	–	1314
2024 Q4	$369K	Buy	+4,720	New	+$379K	0.05%	572
2023 Q1	–	Sell	-45	Closed	-$3.54K	–	1293
2022 Q4	$3.54K	Sell	45 -3,895	-99%	-$313K	﹤0.01%	908
2022 Q3	$292K	Buy	3,940 +3,850	+4,278%	+$276K	0.05%	334
2022 Q2	$6K	Buy	90 +88	+4,400%	+$5.21K	﹤0.01%	607
2022 Q1	$0	Sell	2 -951	-100%	-$51.7K	﹤0.01%	1480
2021 Q4	$51K	Buy	+953	New	+$58.1K	0.02%	450

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dark Forest Capital Management's HAE Position: Q1 2026 in Review

Dark Forest Capital Management reduced its Haemonetics (HAE) stake by 60% in Q1 2026, selling an estimated $592K and leaving 6,154 shares worth $347K. The position accounts for 0.03% of the portfolio, ranked #643.

Dark Forest Capital Management first reported a position in HAE in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.65M in Q3 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Dark Forest Capital Management held 6,154 shares of Haemonetics worth $347K as of Q1 2026.
Dark Forest Capital Management sold 9,085 Haemonetics shares in Q1 2026, an estimated $592K.
Haemonetics made up 0.03% of Dark Forest Capital Management's portfolio in Q1 2026, its #643 holding.
Dark Forest Capital Management first reported a position in Haemonetics in Q4 2021 and has held it in 10 quarters since.
Dark Forest Capital Management's Haemonetics position peaked at $1.65M in Q3 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.